Piper Sandler analyst Michael Lavery maintained a Hold rating on Aurora Cannabis (ACB – Research Report) today and set a price target of $1.00. The company’s shares closed yesterday at $0.56.
Lavery covers the Consumer Defensive sector, focusing on stocks such as Celsius Holdings, Campbell Soup, and Hormel Foods. According to TipRanks, Lavery has an average return of 5.5% and a 51.61% success rate on recommended stocks.
Aurora Cannabis has an analyst consensus of Hold, with a price target consensus of $0.74, which is a 32.14% upside from current levels. In a report released on June 16, CIBC also maintained a Hold rating on the stock with a C$1.00 price target.
See the top stocks recommended by analysts >>
ACB market cap is currently C$247.6M and has a P/E ratio of -0.60.
Based on the recent corporate insider activity of 12 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of ACB in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. It also produces and sells indoor cultivation systems and hemp related food products. The company was founded by Terry Booth and Steve Dobler on December 21, 2006 and is headquartered in Edmonton, Canada.
Read More on ACB:
- Aurora Cannabis price target lowered to C$1 from C$1.75 at CIBC
- Largest borrow rate increases among liquid names
- Rising High: Exclusive talk with cannabis market research firm BDSA
- Aurora Cannabis price target lowered to C$0.80 from C$1.50 at Canaccord
- Unusually active option classes on open June 14th
